the NIH is no longer using Rezulin (troglitazone) in their large Diabetes Prevention Study

July 1998

The NIH is no longer using Rezulin (troglitazone) in theirlarge Diabetes Prevention Study.

This study is designed to see if type 2 diabetes can beprevented or delayed...in patients with impaired glucose tolerance.

Researchers were testing 3 treatment arms...diet and exercise,metformin (Glucophage), and troglitazone (Rezulin).

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote